STAAR Surgical Files Definitive Proxy Materials

TL;DR

STAAR Surgical dropped more proxy docs on 10/8/25. Shareholders, pay attention.

AI Summary

STAAR Surgical Company filed a DEFA14A on October 8, 2025, which includes a press release from their Board of Directors. The filing is a definitive additional material, indicating it's supplementary information for shareholders.

Why It Matters

This filing provides shareholders with important supplementary information regarding STAAR Surgical Company's proxy materials, impacting their voting decisions.

Risk Assessment

Risk Level: low — This filing is a standard proxy statement supplement and does not contain new financial information or significant corporate actions that would inherently increase risk.

Key Players & Entities

• STAAR SURGICAL CO (company) — Registrant
• STAAR (company) — Abbreviation for STAAR Surgical Company
• 0000718937 (company) — Central Index Key
• 953797439 (company) — EIN
• 1911 WALKER AVE (company) — Business Address Street 1
• MONROVIA (company) — Business Address City
• CA (company) — Business Address State
• 91016 (company) — Business Address ZIP
• 6263037902 (company) — Business Phone
• 19920703 (company) — Date of Name Change

FAQ

Key Financial Figures

• $28.00 — a choice: Vote For: Vote Against: $28.00 per share all-cash offer × $18.4
• $18.49 — 28.00 per share all-cash offer × $18.49 per share prior to announcement Certai

Filing Documents

• d36553ddefa14a.htm (DEFA14A) — 32KB
• g36553g1008090739031.jpg (GRAPHIC) — 3KB
• 0001193125-25-234216.txt ( ) — 37KB

Forward-Looking Statements

Forward-Looking Statements The information covered by this communication contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements often contain words such as "anticipate," "believe," "expect," "plan," "estimate," "project," "continue," "will," "should," "may," and similar terms. All statements in this communication that are not performance or achievements to be materially different from what is expressed or implied by the forward-looking statements, including, but not limited to: (1) the occurrence of any event, change or other circumstances that could give rise to the termination of the Alcon merger agreement or could cause the consummation of the proposed transaction to be delayed or to fail to occur; (2) the failure to obtain approval of the proposed transaction from STAAR's stockholders; (3) the failure to obtain certain required regulatory approvals or the failure to satisfy any of the other closing conditions to the completion of the proposed transaction within the expected timeframes or at all; (4) risks related to disruption of management's attention from STAAR's ongoing business operations due to the proposed transaction; (5) the effect of the announcement of the proposed transaction on the ability of STAAR to retain and hire key personnel and maintain relationships with its customers, suppliers and others with whom it does business, or on its operating results and business generally; (6) the ability of STAAR to meet expectations regarding the timing and completion of the transaction; (7) the outcome of any legal proceedings that may be instituted against STAAR related to the proposed transaction; (8) the possibility that STAAR's stock pr

View Full Filing

View this DEFA14A filing on SEC EDGAR